Jared Whitlock on Muck Rack

Jared Whitlock

Verified
  • Health Care and Biotech Reporter, Freelance
San Diego
As seen in: MSN, The New York Times, WIRED Magazine, Fortune, Sydney Morning Herald, Chemical & Engineering News (C&EN), The Irish Times, Baltimore Sun, South Florida Sun Sentinel, STAT and
Features editor @endpts. Reach out privately on Signal: jaredwhitlock.73
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jared

Contact Jared, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Aspen's personalized Parkinson's therapy shows early promise

|
By Jared Whitlock Verified
| Endpoints News Verified
Aspen Neuroscience said its experimental Parkinson’s disease treatment, made from a patient’s own cells, showed encouraging results in a small study. The clinical trial builds … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

Grail names new CEO as Bob Ragusa retires

|
By Jared Whitlock Verified
| Endpoints News Verified
Grail on Thursday announced that its CEO, Bob Ragusa, will retire and is handing the reins to its current president Josh Ofman. The cancer screening … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

China is going after the world's most expensive drugs: Endpoints Signal

|
By Tom Randall, Jared Whitlock Verified
| Endpoints News Verified
Gene therapies were supposed to be competition-proof. They are scientifically complex, require bespoke manufacturing, often go after small patient populations and can cost millions per … Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?
See all 1,482 licensed articles (1,492 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified